Bumble Fund makes investment and partnership deals with AI-driven startup platform with Houston ties

Money moves

Alice founders, Elizabeth Gore (left) and Carolyn Rodz, will talk more about the partnership at Bumble's SXSW event, which the duo attended last year. Getty Images

Rather than just imagining a world where investments made are representative of the diverse population, these two tech companies with Texas roots are teaming up to do something about it.

Austin-based Bumble, a social network with over 50 million users, has reached a deal with Alice, an artificial intelligence-powered platform for entrepreneurs founded by Houstonian Carolyn Rodz and Californian Elizabeth Gore, to use the platform for Bumble's next round of funding.

Additionally — but actually separate from the partnership — Bumble Fund, an early stage corporate investing vehicle focused on businesses founded and led by underrepresented women founders, has invested in Alice in its most recent round of funding.

"We are looking to invest in entrepreneurs whose company purpose solves a problem that disproportionately affects women," says Sarah Jones Simmer, COO at Bumble, in a release. "While we can't fund every promising business and entrepreneur, we strongly believe these companies and founders deserve access to grow, evolve, and thrive. Through community, access to experts, how-to guides, and more, Bumble and Alice are committed to helping women founders find the support and resources they need on their path to success."

The next cohort of fund recipients of the Bumble Fund will be applying through Alice's website, which provides education, support, mentorship and guidance to burgeoning startup founders. Even if applicants don't get funding from Bumble, they leave with a network of resources.

The partnership with Alice will allow Bumble to better connect the dots of its fund recipients using data and AI, and even help to eliminate any bias when it comes to selecting the recipients. The fund is open to all United States entrepreneurs who identify as women. It launched in summer of last year and cuts checks ranging from $5,000 to $250,000, with an average of $25,000.

"For the last several years, only 2 percent of venture capital went to women founders. At Alice and Bumble, we see that as a 98 percent opportunity," says Rodz in the release. "The Bumble Fund, powered by Alice, is that opportunity in action; together, we're going to rewrite the rules of venture capital to be more accessible, more transparent and more supportive for women founders."

Here are all four of Bumble Fund's second round of recipients, according to the release.

  • Alice - founded by Carolyn Rodz and Elizabeth Gore: an AI-powered technology helping entrepreneurs find the right path to start and grow their companies.
  • Gixo - founded by Selina Tobaccowala: a fitness company founded to improve global health and activity rates by democratizing access to live workouts with professional trainers.
  • Translator - founded by Natalie Egan: the world's most advanced diversity & inclusion training system for corporations, schools and nonprofits.
  • Promise - founded by Phaedra Ellis-Lamkins: a technology company that creates cost-effective, equitable, and humane alternatives to incarceration with a mission to get people out of jail and provide ongoing support to help them stay out.

Bumble's first round of investments were in Beautycon, Cleo Capital, Female Founders Fund, Mahmee, and Sofia Los Angeles, a winner of the inaugural Bumble Bizz Pitch Competition.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

NASA unveils Artemis III astronauts at Johnson Space Center in Houston

To the moon

NASA on Tuesday, June 9, revealed the crew for its Artemis III mission, the next step in the space agency's plan to eventually land astronauts on the moon.

The announcement came two months after Artemis II's record-breaking trip around the moon that surpassed the distance record of Apollo 13.

NASA's Randy Bresnik, Frank Rubio, Andre Douglas and the European Space Agency's Luca Parmitano won't fly to the moon or land on the surface. Instead, they’ll orbit Earth while practicing docking their Orion capsule with two lunar landers.

“To the Artemis III crew, we wish you Godspeed on the journey ahead,” said NASA administrator Jared Isaacman.

Elon Musk’s SpaceX and Jeff Bezos’ Blue Origin are racing to deliver the lunar landers. The two-week demo is targeted for 2027. Blue Origin suffered a recent setback when its massive rocket exploded during an engine-firing test on the launch pad in Florida, shaking nearby homes and illuminating the sky with an orange fireball.

NASA's Jeremy Parsons said the setback is a learning opportunity and that the space agency is confident Blue Origin's rocket will be ready in time.

NASA's Artemis program aims to return astronauts to the moon's surface for the first time since the 1970s. A recent revamp of the program announced by Isaacman aims to fast-track it similarly to the Apollo era, adding the upcoming spaceflight around Earth before eyeing a lunar landing in 2028.

“We are certainly humbled as a crew to be able to be your crew that executes this Artemis III mission in space,” said Bresnik, Artemis III commander.

Added Douglas, mission specialist: “My brain — it is going a mile a minute right now. But my heart, it is so warm. It is so full."

In May, NASA awarded hundreds of millions of dollars in contracts to four companies, including Blue Origin, to build landers, rovers and drones for a future moon base. Isaacman said the goal of the moon base is to lay the foundation for a Mars expedition.

Meta to bring $115 million AI data center training initiative to Houston

ai workforce

Meta and Associated Builders and Contractors have entered into a partnership to invest $115 million in training programs for the construction of AI data centers, with a portion of the project launching in Houston.

The companies announced June 8 that they would open America’s Workforce Academies at ABC chapter training centers in Houston; Indianapolis; Baton Rouge, Louisiana; and Columbus, Ohio.

The academies will offer career readiness and safety training, plus five weeks of hands-on education. Participants who complete the program will be granted a job offer from contractors working on Meta projects.

“The AI revolution is bringing change but also historic opportunities,” Dina Powell McCormick, Meta president and vice-chairman, said in a news release. “Skilled workers electrified rural America one pole at a time. They manned the factories that built the arsenal that won World War II. Now a new generation will pour the foundations and lay the fiber that secures American strength in this new age.”

Overall, the Meta and ABC aim for the academies to build a more sustainable pipeline of skilled construction workers and ensure safety and job readiness for the surging number of data center projects underway.

“This new program is an innovative talent solution that is a critical part of addressing the construction industry’s ongoing workforce shortage and creates an accelerated, new-entrant strategy for job seekers ... The sustained demand for data center construction technicians means the industry needs an all-of-the-above approach to address this shortage and grow the construction talent pool,” Michael Bellaman, ABC president and CEO, added in the release.

In Texas, Meta, the parent company of Facebook and Instagram, has launched or broken ground on data centers in El Paso, Fort Worth and Temple. The company announced in March that it planned to grow its El Paso Data center by 1 gigawatt, representing more than a $10 billion investment.

Apart from Meta, Texas has attracted data center development to power other giants like Google and Amazon in recent years. In turn, Texas has been predicted to become the biggest data center market. Commercial real estate services provider JLL reported this spring that the state could topple Northern Virginia as the world’s largest data-center market by 2030. Similarly, CBRE predicted that Houston's data center capacity could double by 2028. Read more here.

New Houston biotech co. lands $30M for pulmonary fibrosis drug

drug money

Most of us can claim a scar or two on our bodies. But when scarring develops inside the body, it’s known as a fibrotic disorder. A freshly launched Houston company, Oorja Bio Inc., is working on a treatment that can help to repair cells and reduce the damage wrought by the growth of fibrotic tissue in patients.

Late last month, Oorja Bio hit the scene with a pair of big announcements. Not only has the company raised a $30 million Series A thanks to founding investor California-based Westlake BioPartners, but it has also already paved the way for a Phase 2 study to take place this year.

Oorja Bio received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA), allowing the company to test its treatment in patients with idiopathic pulmonary fibrosis (IPF), a scarring of the lung tissue. IPF affects more than 150,000 adults in the United States and can result in a range of symptoms from shortness of breath to organ failure and death as it progresses.

Oorja Bio’s lead drug candidate, ORJ-001, was shown in a Phase 1 in-human trial to demonstrate “therapeutically relevant exposure and favorable tolerability” in 64 healthy adult volunteers in whom it was administered daily or weekly, according to a news release. Pre-clinical studies of ORJ-001 showed durable target tissue engagement and biomarker activity in bleomycin-induced lung fibrosis.

Administered subcutaneously, ORJ-001 is intended to improve and even restore function in cells that can reduce the signaling that causes IPF. It stops advancement of IPF and also allows for tissue repair. Currently available treatments for the disease can slow the development of IPF down, but do not address the declining lung function that’s inherent in its progression.

“The clinical and preclinical results from our studies to date give us confidence that ORJ-001 represents a novel treatment approach with the potential to repair and reverse fibrosis and modify disease progression in IPF,” Dr. Janethe Pena, CMO of Oorja Bio, said in the release.

“Our team is energized to deliver on our goal of redefining the future of fibrotic diseases, beginning with ORJ-001,” CEO and founder Sujay Kango added. “As we advance ORJ-001 in the clinic, we are embracing the paradigm shift in our biological understanding of IPF pathology that aligns with the central role of the alveolar epithelium. ORJ-001 was designed with this biology in mind and may provide, for the first time, a therapeutic intervention that repairs and reverses fibrosis and promotes disease modification.”

Most patients live only three to five years following their IPF diagnosis. Soon, ORJ-001 and Oorja Bio could give them a fighting chance.

View All Listings